Premium
VII. Are lymphomas driven by epigenetic lesions?
Author(s) -
Boss Isaac W.,
Melnick Ari M.
Publication year - 2015
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2215
Subject(s) - histone code , histone octamer , epigenomics , histone methylation , chromatin , biology , histone methyltransferase , histone , histone h2a , epigenetics , nucleosome , histone modifying enzymes , ezh2 , microbiology and biotechnology , histone h1 , genetics , dna methylation , gene expression , dna , gene
Keywords: B cell; lymphoma; epigenetic regulation; epigenetic modifier mutations; KMT2D; CBP; P300; EZH2; clinical treatment strategies